214 related articles for article (PubMed ID: 18676884)
1. Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
Sugimura M; Maseda H; Hanaki H; Nakae T
Antimicrob Agents Chemother; 2008 Nov; 52(11):4141-4. PubMed ID: 18676884
[TBL] [Abstract][Full Text] [Related]
2. Effects of quorum sensing-interfering agents, including macrolides and furanone C-30, and an efflux pump inhibitor on nitrosative stress sensitivity in
Suzuki S; Morita Y; Ishige S; Kai K; Kawasaki K; Matsushita K; Ogura K; Miyoshi-Akiyama T; Shimizu T
Microbiology (Reading); 2024 Jun; 170(6):. PubMed ID: 38900549
[TBL] [Abstract][Full Text] [Related]
3. Fuzheng Touxie Jiedu Huayu Decoction inhibits the MexAB-OprM efflux pump and quorum sensing-mediated biofilm formation in difficult-to-treat multidrug resistance Pseudomonas aeruginosa.
Liu T; Xu H; Huang T; Liu G; Cao H; Lin Y; Li Y; Li Y; Yao X
J Ethnopharmacol; 2024 Oct; 332():118365. PubMed ID: 38796070
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
[TBL] [Abstract][Full Text] [Related]
5. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
[TBL] [Abstract][Full Text] [Related]
6. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
Dean CR; Visalli MA; Projan SJ; Sum PE; Bradford PA
Antimicrob Agents Chemother; 2003 Mar; 47(3):972-8. PubMed ID: 12604529
[TBL] [Abstract][Full Text] [Related]
7. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
[TBL] [Abstract][Full Text] [Related]
8. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.
Buyck JM; Plésiat P; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F
Clin Infect Dis; 2012 Aug; 55(4):534-42. PubMed ID: 22573850
[TBL] [Abstract][Full Text] [Related]
9. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel antimicrobial screening system targeting the pyoverdine-mediated iron acquisition system and xenobiotic efflux pumps.
Sato K; Ushioda K; Akiba K; Matsumoto Y; Maseda H; Ando T; Isogai E; Nakae T; Yoneyama H
Molecules; 2015 Apr; 20(5):7790-806. PubMed ID: 25939068
[TBL] [Abstract][Full Text] [Related]
11. RND type efflux pump system MexAB-OprM of Pseudomonas aeruginosa selects bacterial languages, 3-oxo-acyl-homoserine lactones, for cell-to-cell communication.
Minagawa S; Inami H; Kato T; Sawada S; Yasuki T; Miyairi S; Horikawa M; Okuda J; Gotoh N
BMC Microbiol; 2012 May; 12():70. PubMed ID: 22574700
[TBL] [Abstract][Full Text] [Related]
12. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
[TBL] [Abstract][Full Text] [Related]
13. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.
Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P
Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417
[No Abstract] [Full Text] [Related]
14. The mode of action of 2-(thiazol-2-ylthio)-1beta-methylcarbapenems against Pseudomonas aeruginosa: the impact of outer membrane permeability and the contribution of MexAB-OprM efflux system.
Eguchi K; Ueda Y; Kanazawa K; Sunagawa M; Gotoh N
J Antibiot (Tokyo); 2007 Feb; 60(2):129-35. PubMed ID: 17420563
[TBL] [Abstract][Full Text] [Related]
15. Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa.
Middlemiss JK; Poole K
J Bacteriol; 2004 Mar; 186(5):1258-69. PubMed ID: 14973037
[TBL] [Abstract][Full Text] [Related]
16. Mutations in NalC induce MexAB-OprM overexpression resulting in high level of aztreonam resistance in environmental isolates of Pseudomonas aeruginosa.
Braz VS; Furlan JP; Fernandes AF; Stehling EG
FEMS Microbiol Lett; 2016 Aug; 363(16):. PubMed ID: 27412168
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa.
Maseda H; Sawada I; Saito K; Uchiyama H; Nakae T; Nomura N
Antimicrob Agents Chemother; 2004 Apr; 48(4):1320-8. PubMed ID: 15047536
[TBL] [Abstract][Full Text] [Related]
18. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
[TBL] [Abstract][Full Text] [Related]
19. Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa.
Maseda H; Yoneyama H; Nakae T
Antimicrob Agents Chemother; 2000 Mar; 44(3):658-64. PubMed ID: 10681335
[TBL] [Abstract][Full Text] [Related]
20. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Vettoretti L; Plésiat P; Muller C; El Garch F; Phan G; Attrée I; Ducruix A; Llanes C
Antimicrob Agents Chemother; 2009 May; 53(5):1987-97. PubMed ID: 19258280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]